Skip to main content
TipRanks
Go Ultimate75% OFF

Julia Marie Eastland Insider Profile

11 Followers

Julia Marie Eastland, Director at Lantheus, holds 8.02K shares in Lantheus (Ticker: LNTH), holds 79.13K shares in Zentalis Pharmaceuticals (Ticker: ZNTL), holds 16.07K shares in Dynavax (Ticker: DVAX).

Julia Marie Eastland's Trading History

LNTH
Lantheus
May 18, 2026DirectorUninformative Buy―$818.74K
ZNTL
Zentalis Pharmaceuticals
Feb 10, 2026CEO & President, DirectorInformative Sell21.16K$107.62K
DVAX
Dynavax
May 28, 2024―Uninformative Buy―$249.10K
HARP
Harpoon Therapeutics
Mar 11, 2024―Uninformative Sell―$0.00
CALC
CalciMedica
Mar 27, 2023DirectorUninformative Buy―$1.80K
CASC
Cascadian Therapeutics
Mar 13, 2018―Uninformative Sell―$0.00

You May Also Like

Julia Marie Eastland insider profile FAQ

What is the percentage of profitable transactions made by Julia Marie Eastland?
The percentage of profitable transactions made by Julia Marie Eastland is 100%.
What is the average return per transaction made by Julia Marie Eastland?
The average return per transaction made by Julia Marie Eastland is 42.70%.
What stocks does Julia Marie Eastland hold?
Julia Marie Eastland holds: LNTH, DVAX, CASC, HARP, ZNTL, CALC stocks.
What was Julia Marie Eastland's most profitable transaction?
Julia Marie Eastland’s most profitable transaction was an Informative Buy of ZNTL stock on February 4, 2025. The return on the trade was 56.40%.
What is Julia Marie Eastland's role in Lantheus?
Julia Marie Eastland's role in Lantheus is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.